These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 22129607)
61. Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension. van Brummelen P; Gevers Leuven JA; van Gent CM Curr Med Res Opin; 1979; 6(1):24-9. PubMed ID: 222539 [TBL] [Abstract][Full Text] [Related]
62. Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients? Gluba-Brzózka A; Franczyk B; Banach M; Rysz-Górzyńska M Int Urol Nephrol; 2017 Jan; 49(1):155-164. PubMed ID: 27942970 [TBL] [Abstract][Full Text] [Related]
63. High-Density Lipoprotein and Low-Density Lipoprotein Subfractions in Patients with Chronic Kidney Disease. Rysz-Gorzynska M; Gluba-Brzozka A; Banach M Curr Vasc Pharmacol; 2017; 15(2):144-151. PubMed ID: 27697068 [TBL] [Abstract][Full Text] [Related]
64. Influence of baseline values on lipids and lipoprotein changes during amlodipine treatment of hypertension. Ahaneku JE Pharmacol Res; 1998 Sep; 38(3):179-82. PubMed ID: 9782067 [TBL] [Abstract][Full Text] [Related]
65. Effect of moxonidine on lipid subfractions in patients with hypertension. Lumb PJ; McMahon Z; Chik G; Wierzbicki AS Int J Clin Pract; 2004 May; 58(5):465-8. PubMed ID: 15206502 [TBL] [Abstract][Full Text] [Related]
66. Changes in the lipoprotein profile during antihypertensive therapy. Helgeland A; Leren P; Kjeldsen S; Eide I; Foss OP Acta Pharmacol Toxicol (Copenh); 1984; 54 Suppl 1():75-7. PubMed ID: 6711333 [TBL] [Abstract][Full Text] [Related]
67. Improvement of the lipid profile during long-term administration of pindolol and hydrochlorothiazide in patients with hypertension. Samuel P; Chin B; Fenderson RW; Schoenfeld BH; Gonasun LM; Lieberman S Am J Cardiol; 1986 Feb; 57(5):24C-28C. PubMed ID: 3946247 [TBL] [Abstract][Full Text] [Related]
69. Serum cholesterol during ketanserin and propranolol administration in hypertensive patients. Lijnen P; Fagard R; Staessen J; Blaton V; Hollez P; Rorive G; Amery A J Cardiovasc Pharmacol; 1987 Dec; 10(6):647-50. PubMed ID: 2450234 [TBL] [Abstract][Full Text] [Related]
70. Serum lipoproteins during antihypertensive therapy with beta blockers and diuretics: a controlled long-term comparative trial. Middeke M; Weisweiler P; Schwandt P; Holzgreve H Clin Cardiol; 1987 Feb; 10(2):94-8. PubMed ID: 3545579 [TBL] [Abstract][Full Text] [Related]
71. Effects of long-term treatment with metoprolol and hydrochlorothiazide on plasma lipids and lipoproteins. Monmany J; Domingo P; Gomez JA; Sanz F; Roca-Cusachs A; Nolla J; Jane F J Intern Med; 1990 Oct; 228(4):323-31. PubMed ID: 2266340 [TBL] [Abstract][Full Text] [Related]
72. Low IDL-B and high LDL-1 subfraction levels in serum of ALS patients. Delaye JB; Patin F; Piver E; Bruno C; Vasse M; Vourc'h P; Andres CR; Corcia P; Blasco H J Neurol Sci; 2017 Sep; 380():124-127. PubMed ID: 28870551 [TBL] [Abstract][Full Text] [Related]
74. Associations between the lipid profile and the development of hypertension in young individuals - the preliminary study. Chruściel P; Stemplewska P; Stemplewski A; Wattad M; Bielecka-Dąbrowa A; Maciejewski M; Penson P; Bartlomiejczyk MA; Banach M Arch Med Sci; 2022; 18(1):25-35. PubMed ID: 35154522 [TBL] [Abstract][Full Text] [Related]
75. Ramadan fasting ameliorates arterial pulse pressure and lipid profile, and alleviates oxidative stress in hypertensive patients. Al-Shafei AI Blood Press; 2014 Jun; 23(3):160-7. PubMed ID: 24059637 [TBL] [Abstract][Full Text] [Related]
76. Serum lipids and glucose concentrations in subjects using antihypertensive drugs: Finnmark 1977. Arnesen E; Thelle DS; Førde OH; Mjøs OD J Epidemiol Community Health; 1983 Jun; 37(2):141-4. PubMed ID: 6886585 [TBL] [Abstract][Full Text] [Related]
77. Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions. Basile G; Epifanio A; Mandraffino R; Trifirò G J Clin Pharm Ther; 2014 Aug; 39(4):452-4. PubMed ID: 24725285 [TBL] [Abstract][Full Text] [Related]
78. Impact of Smoking Status on Lipoprotein Subfractions: Data from an Untreated Chinese Cohort. Zhao X; Zhang HW; Zhang Y; Li S; Xu RX; Sun J; Zhu CG; Wu NQ; Gao Y; Guo YL; Liu G; Dong Q; Li JJ Biomed Environ Sci; 2017 Apr; 30(4):235-243. PubMed ID: 28494833 [TBL] [Abstract][Full Text] [Related]
79. Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects. Lőrincz H; Katkó M; Harangi M; Somodi S; Gaál K; Fülöp P; Paragh G; Seres I Clin Endocrinol (Oxf); 2014 Sep; 81(3):370-7. PubMed ID: 24303851 [TBL] [Abstract][Full Text] [Related]
80. Lipoprotein Lp(a) in lipoprotein spectrum indentified by Lipoprint LDL system. Oravec S; Dostal E; Gruber K Neuro Endocrinol Lett; 2013; 34(4):309-13. PubMed ID: 23803869 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]